TipRanks
Advertisement
Advertisement

BRRGF Stock Latest News

Oncoinvent Cancels Planned Subsequent Share Offering After Price Slump
Company AnnouncementsOncoinvent Cancels Planned Subsequent Share Offering After Price Slump
5d ago
Oncoinvent Completes Private Placement as Linc AB Stake Rises to 12.21%
PremiumCompany Announcements
Oncoinvent Completes Private Placement as Linc AB Stake Rises to 12.21%
11d ago
Hadean Ventures Funds Lift Oncoinvent Stake to Over 12% After Private Placement
PremiumCompany Announcements
Hadean Ventures Funds Lift Oncoinvent Stake to Over 12% After Private Placement
13d ago
Oncoinvent Registers Share Capital Increase After Private Placement
PremiumCompany Announcements
Oncoinvent Registers Share Capital Increase After Private Placement
13d ago
Oncoinvent’s Radspherin Program Gains Spotlight at EANM and ESMO 2026
PremiumCompany Announcements
Oncoinvent’s Radspherin Program Gains Spotlight at EANM and ESMO 2026
13d ago
Oncoinvent Details Insider Allocation in Retail Share Offering
PremiumCompany AnnouncementsOncoinvent Details Insider Allocation in Retail Share Offering
20d ago
Oncoinvent Shares Begin Trading Ex-Rights Ahead of Planned Offering
Premium
Company Announcements
Oncoinvent Shares Begin Trading Ex-Rights Ahead of Planned Offering
20d ago
Hadean Ventures Funds Adjust Oncoinvent Stake Amid Private Placement Settlement
Premium
Company Announcements
Hadean Ventures Funds Adjust Oncoinvent Stake Amid Private Placement Settlement
20d ago
Oncoinvent Publishes Insider Allocation Details from Recent Private Placement
PremiumCompany Announcements
Oncoinvent Publishes Insider Allocation Details from Recent Private Placement
20d ago
Oncoinvent Sets Terms for Conditional Repair Offering After Private Placement
PremiumCompany Announcements
Oncoinvent Sets Terms for Conditional Repair Offering After Private Placement
20d ago
Oncoinvent Raises NOK 148.5 Million to Advance Radspherin Into Late-Stage Trials
PremiumCompany Announcements
Oncoinvent Raises NOK 148.5 Million to Advance Radspherin Into Late-Stage Trials
20d ago
Oncoinvent Seeks NOK 140 Million to Bolster Ovarian Cancer Trial and Phase 3 Plans
PremiumCompany Announcements
Oncoinvent Seeks NOK 140 Million to Bolster Ovarian Cancer Trial and Phase 3 Plans
21d ago
Oncoinvent Asa Earnings Call Highlights Trial Momentum
PremiumCompany AnnouncementsOncoinvent Asa Earnings Call Highlights Trial Momentum
1M ago
Oncoinvent advances Radspherin trials and IP as losses widen in first half 2026
Premium
Company Announcements
Oncoinvent advances Radspherin trials and IP as losses widen in first half 2026
2M ago
Oncoinvent Sets August Webcast as Radspherin Advances Toward Post-Surgical Cancer Standard
Premium
Company Announcements
Oncoinvent Sets August Webcast as Radspherin Advances Toward Post-Surgical Cancer Standard
2M ago
Oncoinvent’s Radspherin Shows Favorable Dosimetry in Phase 1 Cancer Studies
PremiumCompany Announcements
Oncoinvent’s Radspherin Shows Favorable Dosimetry in Phase 1 Cancer Studies
2M ago
PremiumCompany Announcements
Oncoinvent Hits 50% Enrollment in Phase 2 Radspherin Trial for Ovarian Cancer
4M ago
PremiumCompany Announcements
Oncoinvent Aligns Board Incentives with Equity Grants as Radspherin Advances
5M ago
PremiumCompany Announcements
Oncoinvent Clears AGM Agenda as It Pushes Radspherin Toward Post-Surgical Cancer Market
5M ago
PremiumCompany AnnouncementsOncoinvent Finalizes Major Share Capital Reduction Amid Progress on Cancer Therapy Radspherin
5M ago
Premium
Company Announcements
Oncoinvent Advances Radspherin Program With New Patent, Phase 2 Recruitment and CFO Hire
6M ago
Premium
Company Announcements
Oncoinvent Sets Virtual AGM as Radspherin Development Advances
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >